chr4-1003198-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000203.5(IDUA):​c.1524+41G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 1,300,228 control chromosomes in the GnomAD database, including 12,431 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1756 hom., cov: 30)
Exomes 𝑓: 0.13 ( 10675 hom. )

Consequence

IDUA
NM_000203.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.666

Publications

2 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 4-1003198-G-T is Benign according to our data. Variant chr4-1003198-G-T is described in ClinVar as Benign. ClinVar VariationId is 255524.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
NM_000203.5
MANE Select
c.1524+41G>T
intron
N/ANP_000194.2
IDUA
NM_001363576.1
c.1128+41G>T
intron
N/ANP_001350505.1
IDUA
NR_110313.1
n.1612+41G>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
ENST00000514224.2
TSL:2 MANE Select
c.1524+41G>T
intron
N/AENSP00000425081.2
IDUA
ENST00000247933.9
TSL:1
c.1524+41G>T
intron
N/AENSP00000247933.4
IDUA
ENST00000502829.1
TSL:2
n.367G>T
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.149
AC:
22481
AN:
150816
Hom.:
1762
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.182
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.112
Gnomad ASJ
AF:
0.152
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.228
Gnomad FIN
AF:
0.128
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.131
Gnomad OTH
AF:
0.159
GnomAD2 exomes
AF:
0.152
AC:
88
AN:
580
AF XY:
0.172
show subpopulations
Gnomad AFR exome
AF:
0.0909
Gnomad AMR exome
AF:
0.0192
Gnomad ASJ exome
AF:
0.136
Gnomad EAS exome
AF:
0.143
Gnomad FIN exome
AF:
0.136
Gnomad NFE exome
AF:
0.159
Gnomad OTH exome
AF:
0.167
GnomAD4 exome
AF:
0.132
AC:
151354
AN:
1149304
Hom.:
10675
Cov.:
31
AF XY:
0.132
AC XY:
73147
AN XY:
552692
show subpopulations
African (AFR)
AF:
0.192
AC:
4363
AN:
22694
American (AMR)
AF:
0.0945
AC:
791
AN:
8372
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
2141
AN:
15208
East Asian (EAS)
AF:
0.135
AC:
3510
AN:
25984
South Asian (SAS)
AF:
0.214
AC:
8329
AN:
38876
European-Finnish (FIN)
AF:
0.139
AC:
3701
AN:
26702
Middle Eastern (MID)
AF:
0.198
AC:
623
AN:
3150
European-Non Finnish (NFE)
AF:
0.126
AC:
121374
AN:
961464
Other (OTH)
AF:
0.139
AC:
6522
AN:
46854
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
5428
10855
16283
21710
27138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4980
9960
14940
19920
24900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.149
AC:
22472
AN:
150924
Hom.:
1756
Cov.:
30
AF XY:
0.149
AC XY:
10971
AN XY:
73788
show subpopulations
African (AFR)
AF:
0.181
AC:
7461
AN:
41112
American (AMR)
AF:
0.112
AC:
1704
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.152
AC:
524
AN:
3448
East Asian (EAS)
AF:
0.186
AC:
945
AN:
5080
South Asian (SAS)
AF:
0.229
AC:
1097
AN:
4786
European-Finnish (FIN)
AF:
0.128
AC:
1332
AN:
10408
Middle Eastern (MID)
AF:
0.216
AC:
63
AN:
292
European-Non Finnish (NFE)
AF:
0.131
AC:
8875
AN:
67572
Other (OTH)
AF:
0.156
AC:
327
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
813
1626
2440
3253
4066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
119

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mucopolysaccharidosis type 1 Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.1
DANN
Benign
0.60
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs188458034; hg19: chr4-996986; API